Reuters - Alexion Pharmaceuticals Inc (ALXN.O) posted higher quarterly earnings, helped by a 55 percent jump in revenue from its genetic-disorder drug Soliris, and raised its 2009 full-year outlook.
Reuters - Alexion Pharmaceuticals Inc (ALXN.O) posted higher quarterly earnings, helped by a 55 percent jump in revenue from its genetic-disorder drug Soliris, and raised its 2009 full-year outlook.
